COVID-19 Pfizer's vaccine raises allergy concerns

被引：0
|
作者：
de Vrieze, Jop
机构：
来源：
SCIENCE | 2021年 / 371卷 / 6524期
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：10 / +
页数：2
相关论文
共 50 条
  • [1] Pfizer: The miracle vaccine for COVID-19?
    Badiani, A. A.
    Patel, J. A.
    Ziolkowski, K.
    Nielsen, F. B. H.
    PUBLIC HEALTH IN PRACTICE, 2020, 1
  • [2] The journey of a lifetime - development of Pfizer's COVID-19 vaccine
    Thorn, Chelsea R.
    Sharma, Divya
    Combs, Rodney
    Bhujbal, Sonal
    Romine, Jennifer
    Zheng, Xiaolu
    Sunasara, Khurram
    Badkar, Advait
    CURRENT OPINION IN BIOTECHNOLOGY, 2022, 78
  • [3] Real World Experience of Managing Covid-19 Vaccine Allergy Concerns
    Leeman, Lucy
    Davis, Georgina
    Mullan, Daniel
    Whyte, Andrew
    Wallace, Josef
    Bethune, Claire
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (12): : 1669 - 1669
  • [4] Pfizer-BioNTech COVID-19 Vaccine
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1642): : 16 - 16
  • [5] No evidence of TTS risk with Pfizer/BioNTech's COVID-19 vaccine
    Reactions Weekly, 2021, 1854 (1) : 5 - 5
  • [6] Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
    Reactions Weekly, 2021, 1878 (1) : 8 - 8
  • [7] Outcomes from New Consultations to Allergy Clinic for COVID-19 Vaccine Concerns
    Boderman, Samuel
    Kakumanu, Sujani
    Viswanathan, Ravi
    Rosenberg, Daniel
    Moss, Mark
    Mathur, Sameer
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB97 - AB97
  • [8] Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
    Reactions Weekly, 2021, 1884 (1) : 6 - 6
  • [9] Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy
    McSweeney, Morgan D. D.
    Mohan, Manoj
    Commins, Scott P. P.
    Lai, Samuel K. K.
    FRONTIERS IN ALLERGY, 2021, 2
  • [10] COVID-19 mRNA vaccine allergy
    Risma, Kimberly A.
    CURRENT OPINION IN PEDIATRICS, 2021, 33 (06) : 610 - 617
12345